Cassava Sciences (SAVA): Evaluating Valuation After CEO's Major Share Purchase and Alzheimer's Program Withdrawal [Yahoo! Finance]
Cassava Sciences, Inc. (SAVA)
Last cassava sciences, inc. earnings: 8/12 08:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Just weeks after halting the company's long-running Alzheimer's program, Barry stepped in to purchase a large chunk of shares. This marked his first insider buy in over a year. For investors, this move stands out and signals that leadership sees unrealized value in Cassava's pipeline and long-term vision, even after the setback in clinical trials. The CEO's investment was followed by a rapid 50% surge in Cassava Sciences' share price, reversing much of the gloom that had settled over the stock in the past year. While one significant move cannot erase the company's multi-year losses, this insider activity has clearly shifted market sentiment, at least in the near term. In the past month alone, Cassava's stock has climbed nearly 30%, and momentum has accelerated even as the firm remains under pressure from its clinical and financial hurdles. This recent burst of optimism has investors asking a tough question: Is Cassava Sciences a bargain with overlooked upside, or is the market now
Show less
Read more
Impact Snapshot
Event Time:
SAVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAVA alerts
High impacting Cassava Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
SAVA
News
- Cassava Sciences rises 10% after market close on CEO stock buy [Seeking Alpha]Seeking Alpha
- Cassava Reports Q3 2025 Financials Results and Provides Business UpdateGlobeNewswire
- Cassava Sciences (NASDAQ:SAVA) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their RightsBusiness Wire
- Cassava Sciences Appoints Dawn C. Bir to the Board of DirectorsGlobeNewswire
SAVA
Earnings
- 3/3/25 - Beat
SAVA
Sec Filings
- 12/3/25 - Form 8-K
- 11/25/25 - Form 4
- 11/24/25 - Form 4
- SAVA's page on the SEC website